Holen Sie sich die Stockscreener-App
0.00
100.00%
-70.50
Schlusskurs vom Vortag:
$70.50
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$7.43B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$83.86
Metsera Inc Stock (MTSR) Company Profile
Firmenname
Metsera Inc
Sektor
Branche
Telefon
(212) 784-6595
Adresse
3 WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MTSR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
0.00 | 7.43B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2025-06-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-02-25 | Eingeleitet | BofA Securities | Buy |
| 2025-02-25 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Metsera Inc Aktie (MTSR) Neueste Nachrichten
Pfizer (PFE) Stock on December 6, 2025: Metsera Deal, 2025 Guidance and What Wall Street Expects Next - ts2.tech
Metsera Inc Stock Analysis and ForecastStraddle and Strangle Trades & Outstanding Profit Strategies - earlytimes.in
Pfizer (PFE) Stock Today: Price, Metsera Obesity Deal, 2025–2026 Forecast and Key Risks - ts2.tech
Pfizer Stock (PFE) Today – Price, Metsera Obesity Bet, RSV Vaccine Tailwinds and 2026 Forecast (3 December 2025) - ts2.tech
Pfizer : November Social Media Round-Up—Third-Quarter Earnings, Metsera Acquisition, and MoreUpdates & StatementsAlbert BourlaArtificial IntelligenceBusinessCancerHealth Equity - marketscreener.com
November Social Media Round-Up—Third-Quarter Earnings, Metsera Acquisition, and More - Pfizer
Will Metsera Inc. stock benefit from automationJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Why Metsera Inc. stock is seen as undervaluedJuly 2025 Market Mood & AI Driven Stock Price Forecasts - Newser
Pfizer (PFE) Stock Outlook Before the December 1, 2025 Open: Price, Metsera Obesity Deal, Dividend Payout and Wall Street Forecasts - ts2.tech
Pfizer Stock Price ForecastPFE Shares Surges Toward $30 With Metsera Deal & $7.2B Cost Cuts Drive 2026 Recovery - TradingNEWS
Pfizer (PFE) Stock on November 30, 2025: Institutional Buying, Metsera Deal and a 6.7% Dividend Yield - ts2.tech
Pfizer: The Pharma Giant To Buy Right Now (NYSE:PFE) - Seeking Alpha
Aug PostEarnings: Will Metsera Inc. stock reach Wall Street targetsExit Point & Daily Volume Surge Signals - BỘ NỘI VỤ
Novo, Pfizer Square Off Over Metsera in Obesity-Drug Tussle - MSN
Guggenheim Lifts PT on Pfizer Inc. (PFE) to $35 From $33, Keeps a Buy Rating - MSN
Key facts: Novo Nordisk shares rise; partners in UAE; bids for Metsera - TradingView
Is Pfizer Stock A Buy After It Clinches The $10 Billion Takeover Of Metsera? - Investor's Business Daily
PFE Stock Today (Nov. 25, 2025): Pfizer Rises on Metsera Obesity Deal, PADCEV Approval and Options Surge - ts2.tech
Pfizer’s CFO on building a post-Covid future and how it won the fight for Metsera - Sherwood News
No plane sailing for Novo Nordisk - MarketScreener
Pfizer (PFE) on 23 Nov 2025: Metsera Deal, Cancer Win and a 7% Dividend - ts2.tech
Novo Nordisk Reportedly Refrains From Backing Down In Metsera Acquisition Battle, Sweetens Bid Further - MSN
Promising Mid Cap Stocks Worth WatchingNovember 20th - MarketBeat
Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors - ts2.tech
Can Metsera Inc. stock sustain free cash flow growthJuly 2025 Rallies & Intraday High Probability Alerts - newser.com
Promising Mid Cap Stocks To ConsiderNovember 17th - MarketBeat
Top Mid Cap Stocks To Follow NowNovember 19th - MarketBeat
Pfizer exec challenges Novo Nordisk, Eli Lilly after Metsera win - medwatch.com
Tools to monitor Metsera Inc. recovery probabilityQuarterly Profit Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Metsera Inc. stock a safe investment in uncertain marketsJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
How to build a custom watchlist for Metsera Inc.Trade Exit Report & Free AI Powered Buy and Sell Recommendations - newser.com
How Metsera Inc. stock performs in stagflationTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Jefferies 25: Pfizer Still Hungry For Anti-Obesity Deals After Metsera - Citeline News & Insights
Best Mid Cap Stocks To Add to Your WatchlistNovember 14th - MarketBeat
Pfizer intends to raise $5 billion to finance the deal with Metsera - AKM.RU
Is Metsera Inc. forming a bottoming baseJuly 2025 Final Week & Weekly Top Performers Watchlists - newser.com
Pfizer to seek oral obesity drugs globally after Metsera deal- CEO - Investing.com
Why Metsera Inc. stock appeals to analystsQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
Pfizer (PFE) Plans $5 Billion Bond Issuance to Fund Metsera Acqu - GuruFocus
(11/19/25) PFE: The Winner in the Metsera Bidding War - moneyshow.com
PFE- The Winner in the Metsera Bidding War - Yahoo Finance
Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market - AOL.com
Pfizer sells US$6bn of bonds for Metsera acquisition - IFR Asia
Pfizer Kicks Off US Dollar Bond Sale to Help Fund Metsera Deal - Bloomberg.com
Pfizer reportedly seeking $5B bond sale for Metsera acquisition - MSN
Pfizer (PFE) Plans $5B Bond Offering to Support Metsera Acquisition - GuruFocus
Pfizer seeking $5B bond sale for Metsera deal (PFE:NYSE) - Seeking Alpha
Pfizer (PFE) Taps Bond Market for $5 Billion to Fund Metsera Acquisition - TipRanks
Pfizer Seeking at Least $5 Billion in Bond Sale for Metsera Deal, Bloomberg Reports - MarketScreener
Stock Watch: Addressing Pfizer’s Pandemic Revenue Replacement - Citeline News & Insights
Metsera Inc. stock chart pattern explainedPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Finanzdaten der Metsera Inc-Aktie (MTSR)
Es liegen keine Finanzdaten für Metsera Inc (MTSR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):